| Literature DB >> 28166751 |
Mariko Carey1,2, Robert Sanson-Fisher3,4, Finlay Macrae5,6, Emilie Cameron3,4, David Hill5,7, Catherine D'Este8, Christopher Doran9.
Abstract
BACKGROUND: Colorectal cancer (CRC) survivors are at increased risk of developing the disease again. Surveillance guidelines are aimed at maximising the early detection of recurring or new cancers and pre-cancerous polyps. The frequency and type of surveillance recommended depends on the type of treatment for the initial CRC, the extent of colonoscopic investigation prior to treatment and the results of previous surveillance tests. This paper aimed to test the effect of a paper-based educational intervention to improve adherence to colonoscopy following treatment for colorectal cancer.Entities:
Keywords: Bowel cancer; Colonoscopy; Colorectal cancer; Guideline adherence; Implementation science; Randomized controlled trial; Surveillance
Mesh:
Year: 2017 PMID: 28166751 PMCID: PMC5294678 DOI: 10.1186/s12885-017-3095-x
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Flowchart of recruitment of index cases (IC) to the study
Comparison of adherence classification using the old and new guidelines
| Guidelines recommendations | ||
| Examples | Old guidelines: | New guidelines: |
| Classification of adherence | ||
| Colonoscopy at diagnosis; no colonoscopy reported at 12 month follow up | Adherent | Non-adherent |
| Colonoscopy at diagnosis; followed by colonoscopy 12 months later | Non-adherent | Adherent |
| Colonoscopy at diagnosis, and then another colonoscopy within 6 months of surgery | Adherent | Adherent |
| Colonoscopy 6 months post surgery; no subsequent colonoscopy reported at 12 month follow up | Adherent | Adherent |
| Colonoscopy 6 months post surgery; subsequent colonoscopy reported at 12 month follow up | Non-adherent | Non-adherent |
aWe were unable to tell if the colonoscopy performed at diagnosis visualised the entire colon. Therefore, any cases where this criteria was crucial to determining adherence were classified as adherent. For example if a colonoscopy was performed at baseline and then again at 6 months, we assumed that the diagnostic colonoscopy did not enable visualisation of the entire colon, and therefore classified the patient as adherent
Characteristics of the sample
| Variable | Control | Intervention |
|---|---|---|
|
|
| |
|
|
| |
| Age ( | Mean = 66 (SD = 11) | Mean = 68 (SD = 12) |
| under 50 | 16 (5%) | 18 (6%) |
| 50–59 | 60 (20%) | 55 (18%) |
| 60–69 | 98 (33%) | 83 (27%) |
| 70–79 | 85 (28%) | 81 (27%) |
| over 80 | 40 (13%) | 68 (22%) |
| Male ( | 171 (57%) | 154 (50%) |
| Married/defacto ( | 230 (77%) | 205 (67%) |
| Born in Australia ( | 205 (77%) | 223 (80%) |
| Urban dwelling ( | 202 (68%) | 194 (64%) |
| Education ( | ||
| University or vocational training | 99 (33%) | 200 (33%) |
| Secondary school completed | 44 (14%) | 87 (14%) |
| Secondary school not completed | 161 (53%) | 315 (52%) |
| Employed ( | 106 (32%) | 98 (34%) |
| Private health insurance ( | 197 (66%) | 201 (66%) |
| Previous cancer diagnosis ( | 33 (11%) | 54 (18%) |
| Left-sided tumour ( | 177 (59%) | 162 (54%) |
| Disease stage ( | ||
| TNM Stage I | 95 (32%) | 98 (33%) |
| TNM Stage II | 100 (34%) | 115 (38%) |
| TNM Stage III | 99 (34%) | 88 (29%) |
| Returned a follow up survey ( | 246 (82%) | 257 (84%) |
| Died in follow-up period | 11 (4%) | 7 (2%) |
| Days between diagnosis and Intervention ( | Median = 219 (IQR:171-281) | Median = 226 (IQR:189-281) |
Adherence to surveillance guidelines in the intervention and control groups
| Intervention | Control | Total | |
|---|---|---|---|
| Adherent at follow up | 80(32%) | 67(27%) | 147(29%) |
| Non-adherent at follow up | 174(69%) | 179(73%) | 353(71%) |
| Under screened | 10(3.9%) | 17(6.9%) | 27(5.4%) |
| Over screened | 164(65%) | 162(66%) | 326(65%) |
Multiple logistic regression of factors associated with adherence to surveillance guidelines at follow up compared to those who were over screened (n = 455)
| Variable | Adherent to surveillance guidelines | Odds ratio |
|
|---|---|---|---|
| (95% CI) | |||
| Experimental group | |||
| Control | 55 (26%) | REF | |
| Intervention | 66 (29%) | 1.01 (0.64–1.6) | 0.954 |
| Age | |||
| under 50 | 3 (14%) | 0.44 (0.11–1.83) | |
| 50–59 | 14 (17%) | 0.56 (0.24–1.34) | |
| 60–69 | 31 (22%) | 0.77 (0.42–1.4) | |
| 70–79 | 39 (31%) | REF | |
| over 80 | 34 (47%) | 2 (1.05–3.98) | 0.049 |
| Sex | |||
| Male | 68 (29%) | REF | |
| Female | 53 (26%) | 0.91 (0.56–1.47) | 0.697 |
| Highest level of education | |||
| University or vocational training | 34 (22%) | REF | |
| Secondary school completed | 23 (34%) | 1.6 (0.8–3.12) | |
| Secondary school not completed | 64 (29%) | 1.03 (0.6–1.77) | 0.367 |
| Relationship status | |||
| Single | 36 (33%) | REF | |
| Married/defacto | 85 (26%) | 1.01 (0.58–1.76) | 0.97 |
| Employment status | |||
| Not employed | 95 (33%) | REF | |
| Employed | 26 (17%) | 0.58 (0.3–1.12) | 0.107 |
| Australian born | |||
| No | 24 (26%) | REF | |
| Yes | 97 (28%) | 1.2 (0.68–2.14) | 0.519 |
| Location or residence | |||
| Rural | 52 (34%) | REF | |
| Urban | 69 (24%) | 0.65 (0.4–1.05) | 0.081 |
| Private health insurance | |||
| No | 44 (34%) | REF | |
| Yes | 77 (25%) | 0.81 (0.49–1.33) | 0.406 |
| Disease stage | |||
| TNM Stage I | 45 (31%) | REF | |
| TNM Stage II | 44 (27%) | 0.67 (0.39–1.16) | |
| TNM Stage III | 32 (24%) | 0.76 (0.43–1.36) | 0.349 |
| Cancer site | |||
| Right sided | 45 (24%) | REF | |
| left-sided | 76 (30%) | 1.8 (1.13–3.02) | 0.014 |
| Saw specialist for follow up care | |||
| No | 14 (61%) | REF | |
| Yes | 107 (26%) | 0.35 (0.14–0.91) | 0.031 |
* P value for adjusted Wald test